Skip to content

Clinical trials

Completed Phase 3 Diabetic Retinopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Phase: Phase 3 Status: Completed Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20041
20052
20062
20072
20081
20091
20113
20121
20131
20161
20184
20192
20201
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)6
Jaeb Center for Health Research4
Novartis Pharmaceuticals4
Chromaderm, Inc.3
Bausch & Lomb Incorporated2
Novartis2
Aurolab1
Glostrup University Hospital, Copenhagen1
Hoffmann-La Roche1
Incepta Pharmaceuticals Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy36
Macular Edema8
Diabetes Mellitus5
Retinal Diseases4
Vision Disorders3
Vitreous Hemorrhage3
Blindness2
Eye Diseases2
Retinal Degeneration2
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.